SE435839B - Analogiforfarande for framstellning av ergopeptidalkaloidderivat - Google Patents

Analogiforfarande for framstellning av ergopeptidalkaloidderivat

Info

Publication number
SE435839B
SE435839B SE7709645A SE7709645A SE435839B SE 435839 B SE435839 B SE 435839B SE 7709645 A SE7709645 A SE 7709645A SE 7709645 A SE7709645 A SE 7709645A SE 435839 B SE435839 B SE 435839B
Authority
SE
Sweden
Prior art keywords
ergopeptidalcaloid
derivatives
preparation
analogy procedure
analogy
Prior art date
Application number
SE7709645A
Other languages
English (en)
Swedish (sv)
Other versions
SE7709645L (sv
Inventor
P Stutz
P Stadler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1128776A external-priority patent/CH623592A5/de
Priority claimed from CH1128676A external-priority patent/CH623591A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7709645L publication Critical patent/SE7709645L/xx
Publication of SE435839B publication Critical patent/SE435839B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7709645A 1976-09-06 1977-08-29 Analogiforfarande for framstellning av ergopeptidalkaloidderivat SE435839B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1128776A CH623592A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CH1128676A CH623591A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives

Publications (2)

Publication Number Publication Date
SE7709645L SE7709645L (sv) 1978-03-07
SE435839B true SE435839B (sv) 1984-10-22

Family

ID=25708069

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709645A SE435839B (sv) 1976-09-06 1977-08-29 Analogiforfarande for framstellning av ergopeptidalkaloidderivat

Country Status (15)

Country Link
JP (1) JPS5331698A (fr)
AU (1) AU512027B2 (fr)
CA (1) CA1105007A (fr)
DE (1) DE2738730A1 (fr)
DK (1) DK147390C (fr)
ES (1) ES462080A1 (fr)
FI (1) FI64942C (fr)
FR (1) FR2363571A1 (fr)
GB (2) GB1590149A (fr)
IE (1) IE46152B1 (fr)
IL (1) IL52896A (fr)
NL (1) NL7709683A (fr)
NZ (1) NZ185098A (fr)
PT (1) PT67003B (fr)
SE (1) SE435839B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140042868A (ko) * 2011-06-23 2014-04-07 맵 파마슈티컬스, 인코포레이티드 신규한 플루오로에르골린 유사체

Also Published As

Publication number Publication date
JPS5331698A (en) 1978-03-25
IE46152B1 (en) 1983-03-09
GB1590149A (en) 1981-05-28
NL7709683A (nl) 1978-03-08
AU512027B2 (en) 1980-09-18
GB1590150A (en) 1981-05-28
FR2363571A1 (fr) 1978-03-31
FI772557A7 (fi) 1978-03-07
DK147390B (da) 1984-07-16
NZ185098A (en) 1980-04-28
PT67003A (en) 1977-10-01
SE7709645L (sv) 1978-03-07
FI64942B (fi) 1983-10-31
PT67003B (en) 1979-05-14
IL52896A0 (en) 1977-11-30
FI64942C (fi) 1984-02-10
FR2363571B1 (fr) 1980-04-18
AU2857277A (en) 1979-03-15
ES462080A1 (es) 1978-12-01
CA1105007A (fr) 1981-07-14
DK382777A (da) 1978-03-07
IE46152L (en) 1978-03-06
IL52896A (en) 1980-07-31
DE2738730A1 (de) 1978-03-16
DK147390C (da) 1985-02-04

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
NO772960L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
SE7707407L (sv) Forfarande for framstellning av cefamderivat
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat